Device manufacturer Berry Global says that it intends to hire 500 employees over 8 years to staff its new manufacturing facility in Bangalore, India, which will produce a variety of products, including nasal and inhaled drug delivery devices. The company had announced plans for the site in August 2021. Berry says that the Bangalore site has received International … [Read more...] about Berry to open new manufacturing facility in Bangalore, India
Products and Services
Vero Biotech closes $30 million financing to support commercialization of Genosyl tankless iNO system
Vero Biotech announced an investment of $30 million from Petrichor Healthcare Capital Management that will be used for commercialization of Vero's Genosyl DS tankless inhaled nitric oxide system. The company recently announced that it had received FDA approval for the third generation Genosyl DS for delivery of iNO to increase oxygenation in newborn infants with … [Read more...] about Vero Biotech closes $30 million financing to support commercialization of Genosyl tankless iNO system
Acorda Therapeutics announces new supply agreement with Catalent for manufacture of Inbrija inhaled dry powder levodopa
Acorda Therapeutics announced that it has signed a new supply agreement with Catalent that reduces the amount of product that the company is required to buy annually from $18 million to $8.5 million for 2023 and $15.5 million for 2024. From 2025 on, the announcement says, Acorda will pay a fixed amount per capsule "based on the amount of Inbrija needed in the US and … [Read more...] about Acorda Therapeutics announces new supply agreement with Catalent for manufacture of Inbrija inhaled dry powder levodopa
Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility
Florida-based CDMO Formulated Solutions announced that it has acquired a 455,000 sq ft production facility in Cleveland, TN, USA that includes two buildings fitted with pharmaceutical production and packaging lines for a variety of dose forms such as liquids, bag-on-valve aerosols, and nasal sprays. The Tennessee facility was most recently owned by German skincare … [Read more...] about Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility
Third Pole gets $32 million to support development of eNOcare inhaled nitric oxide device
Inhaled nitric oxide (iNO) delivery device developer Third Pole Therapeutics announced that it has received a $32 million equity investment "from a large medical device innovator." In February 2022, the company announced the closing of a $25 million financing. Chiesi acquired global rights to develop and commercialize Third Pole's tankless iNO technology in April … [Read more...] about Third Pole gets $32 million to support development of eNOcare inhaled nitric oxide device
Experic raises $14 million in Series B financing led by Harro Höfliger
CDMO Experic, which offers development and manufacturing services for DPIs, announced that it has closed a $14 million series B funding led by East Seattle Partners and inhaler filling experts Harro Höfliger Packaging Systems. The company said that the new investment will go toward expansion of its facility in Cranbury, NJ, USA in response to "extraordinary … [Read more...] about Experic raises $14 million in Series B financing led by Harro Höfliger
Micro-Sphere adds lab-scale electrostatic spray drying capabilities
CDMO Micro-Sphere, which offers spray drying and capsule filling for DPI formulations, said that it has now added new particle engineering R&D space with FluidAir PolarDry electrostatic spray drying technology. The company recently announced the addition of new inhalation testing laboratory space at its site in Monteggio, Switzerland. The PolarDry system works at … [Read more...] about Micro-Sphere adds lab-scale electrostatic spray drying capabilities
Adherium’s Hailie sensor gets 510(k) clearance for use with Ventolin, Advair, and Flovent MDIs
Adherium announced that the FDA has granted 510(k) clearance for use of Adherium's next-generation Hailie inhaler sensor with GSK's Ventolin, Advair, and Flovent MDIs. The company had announced submission of the 510(k) application in August 2022. Adherium CEO Rick Legleiter said, "This is the third 510(k) market clearance of the next-generation Hailie sensors … [Read more...] about Adherium’s Hailie sensor gets 510(k) clearance for use with Ventolin, Advair, and Flovent MDIs
Kindeva Drug Delivery to merge with Meridian Medical Technologies
CDMO Kindeva Drug Delivery, which specializes in inhalation, intradermal, and transdermal drug delivery, has announced that it will merge with fellow Altaris Capital Partners company Meridian Medical Technologies, which specializes in autoinjectors. Altaris acquired Kindeva (formerly 3M Drug Delivery Systems) from 3M in 2020 and acquired Meridian from Pfizer in 2021. … [Read more...] about Kindeva Drug Delivery to merge with Meridian Medical Technologies
FDA provides funding for Simulations Plus and University of Florida project for validation of PBPK models for inhaled drugs
According to modeling software company Simulations Plus, the FDA has awarded the company a contract for a project that is intended to improve models of pulmonary absorption of inhaled drugs, with a goal of creating "the foundation of a viable alternative to in vivo studies for the establishment of bioequivalence (BE) for OIDPs." The company said that Rodrigo … [Read more...] about FDA provides funding for Simulations Plus and University of Florida project for validation of PBPK models for inhaled drugs